About Us

PMC is working to advance personalized medicine on behalf of member institutions from every sector of the health care ecosystem.

PMC Paves the Way for Personalized Medicine

Based in Washington, D.C., PMC works closely with business executives, clinicians, lawmakers, and agency officials to advance strategic priorities in three areas:


To provide a foundation of awareness and understanding, PMC educates decision-makers and patients about how personalized medicine can make health care more effective and efficient.


To expand the field of available tests and therapies, PMC advocates for biomedical research investments. To ensure patient access, it promotes modernized regulatory and reimbursement policies.

Evidence Development

To encourage the swifter adoption of personalized medicine, PMC helps build the evidence base necessary to demonstrate the clinical and economic value of personalized medicine.


The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers, and payers, promotes the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and health systems.

Believing that paradigm shifts, especially in medicine, do not happen just because the science and new technologies suggest they should, PMC supports investment in and adoption of personalized medicine through education, advocacy, and evidence development.


Some 20 institutions representing different sectors of the health system launched PMC in 2004 to improve upon medical paradigms that base treatment decisions exclusively on population averages. Today, PMC’s more than 200 members are leading the movement toward personalized medicine to benefit patients and health systems around the world.
Research, Education &
Clinical Care Institutions
0 %